Selecta Biosciences, Inc.
SELB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $452 | $298 | $1,100 | $21,175 |
| % Growth | 51.7% | -72.9% | -94.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $2,507 |
| Gross Profit | $0 | $0 | $0 | $18,668 |
| % Margin | 0% | 0% | 0% | 88.2% |
| R&D Expenses | $13,802 | $14,869 | $14,674 | $4,303 |
| G&A Expenses | $7,716 | $7,240 | $8,315 | $11,712 |
| SG&A Expenses | $7,716 | $7,240 | $8,315 | $11,712 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,518 | $22,109 | $22,989 | $16,015 |
| Operating Income | $0 | -$21,811 | $0 | $50,084 |
| % Margin | 0% | -7,319.1% | 0% | 236.5% |
| Other Income/Exp. Net | $0 | $37,697 | $0 | -$85,169 |
| Pre-Tax Income | -$35,902 | $15,886 | -$17,710 | -$35,085 |
| Tax Expense | $0 | $0 | $0 | -$5,185 |
| Net Income | -$35,902 | $15,886 | -$17,710 | -$31,282 |
| % Margin | -7,942.9% | 5,330.9% | -1,610% | -147.7% |
| EPS | -1.38 | 0.51 | -0.11 | -0.2 |
| % Growth | -370.6% | 563.6% | 45% | – |
| EPS Diluted | -1.38 | 0.5 | -0.11 | -0.2 |
| Weighted Avg Shares Out | 26,003 | 25,980 | 155,110 | 155,110 |
| Weighted Avg Shares Out Dil | 26,003 | 26,447 | 155,110 | 155,110 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,548 | $1,748 | $2,015 | $6,221 |
| Interest Expense | $0 | $0 | $0 | -$2,833 |
| Depreciation & Amortization | $606 | $0 | $0 | -$826 |
| EBITDA | -$35,296 | -$21,811 | $0 | -$40,126 |
| % Margin | -7,808.8% | -7,319.1% | 0% | -189.5% |